Corbus Pharmaceuticals Holdings, Inc. Money Market Funds, at Carrying Value
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Money Market Funds, at Carrying Value of $63.23 million as of 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Notes
us-gaap:MoneyMarketFundsAtCarryingValue · last filed 2021-05-13
- 2021-03-31: Money Market Funds, at Carrying Value $63.23M.
- 2020-12-31: Money Market Funds, at Carrying Value $84.19M; Money Market Funds, at Carrying Value as first filed $83.61M.
- 2020-09-30: Money Market Funds, at Carrying Value $77.91M.
- 2020-06-30: Money Market Funds, at Carrying Value $62.70M.
| Period end | Money Market Funds, at Carrying Value | Money Market Funds, at Carrying Value as first filed |
|---|---|---|
| 2021-03-31 | $63.23M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $84.19M 10-Q · filed 2021-05-13 | $83.61M 10-K · filed 2021-03-15 |
| 2020-09-30 | $77.91M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $62.70M 10-Q/A · filed 2020-08-31 | |
| 2020-03-31 | $45.04M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $30.86M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $49.66M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $71.61M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $88.62M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $40.94M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $55.24M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $63.19M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $70.91M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $62.33M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $36.38M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $42.86M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $48.83M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $13.86M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $18.76M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $21.99M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $9.60M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $12.08M 10-K · filed 2017-03-08 | |
| 2015-09-30 | $13.06M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $9.03M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $4.92M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $6.25M 10-K · filed 2016-03-28 | |
| 2013-12-31 | $202.26K 10-K · filed 2015-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |